Epibiotech Co., Ltd. (XKON:446440)
14,560
-2,430 (-14.30%)
At close: Oct 2, 2026
| Market Cap | 33.59B -11.1% |
| Revenue (ttm) | 449.62M +15.9% |
| Net Income | -5.06B |
| EPS | -2,966.00 |
| Shares Out | 2.31M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 450 |
| Open | 15,000 |
| Previous Close | 16,990 |
| Day's Range | 14,450 - 16,990 |
| 52-Week Range | 10,880 - 20,900 |
| Beta | 0.57 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |